Please use this identifier to cite or link to this item:
https://bura.brunel.ac.uk/handle/2438/34209Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lau, Doreen | - |
| dc.date.accessioned | 2026-11-20T09:33:49Z | - |
| dc.date.available | 2026-11-20T09:33:49Z | - |
| dc.date.issued | 2026-10-16 | - |
| dc.identifier.citation | Lau, D. (2026) 'Seeing the big picture: imaging in immunotherapy', Immunotherapy Advances, 6(1), ltag024, pp. 1–3. doi: 10.1093/immadv/ltag024. | en_US |
| dc.identifier.uri | https://bura.brunel.ac.uk/handle/2438/34209 | - |
| dc.description | Data availability: Not applicable. | en_US |
| dc.description | Editorial. | en_US |
| dc.description | Acknowledgement: D.L. is a Working Group Co-Leader of the IMMUNO-model EU COST Action (CA21135), which focuses on modelling immunotherapy response and toxicity in cancer. | en_US |
| dc.description.abstract | Immunotherapies have transformed the treatment of cancer and are increasingly reshaping the management of autoimmune and infectious diseases. By modulating the immune system, these therapies have opened new opportunities to restore protective immunity and overcome immune dysfunction. Despite remarkable clinical successes, therapeutic responses remain highly variable, with many patients failing to respond or developing acquired resistance over time [1]. Understanding the dynamic interplay between immune cells, diseased tissues, and therapeutic interventions has therefore become one of the defining challenges in immunology. As the field continues to evolve, there is an increasing need for technologies that not only characterize immune phenotypes but also enable us to see the ‘big picture’ of when, where, and how immune responses develop, evolve, and determine therapeutic outcome. ... | en_US |
| dc.description.sponsorship | None declared | en_US |
| dc.format.extent | pp. 1–3 | - |
| dc.format.medium | Electronic | - |
| dc.language | English | - |
| dc.language.iso | en | en_US |
| dc.publisher | Oxford University Press (OUP) on behalf of the British Society for Immunology | en_US |
| dc.rights | Re-use licence for this version: Creative Commons Attribution 4.0 International | - |
| dc.rights | Licence for published version: Creative Commons Attribution 4.0 International | - |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | - |
| dc.subject | immunotherapy | en_US |
| dc.subject | magnetic resonance imaging (MRI) | en_US |
| dc.subject | molecular imaging | en_US |
| dc.subject | positron emission tomography (PET) | en_US |
| dc.subject | theranostics | en_US |
| dc.title | Seeing the big picture: imaging in immunotherapy | en_US |
| dc.type | Article | en_US |
| dc.date.dateAccepted | 2026-10-02 | - |
| dc.identifier.doi | https://doi.org/10.1093/immadv/ltag024 | - |
| dc.relation.isPartOf | Immunotherapy Advances | - |
| pubs.issue | 1 | - |
| pubs.publication-status | Published | - |
| pubs.volume | 6 | - |
| dc.identifier.eissn | 2732-4303 | - |
| dc.rights.license | https://creativecommons.org/licenses/by/4.0/legalcode.en | - |
| dcterms.dateAccepted | 2026-10-02 | - |
| dcterms.issued | 2026-10-16 | - |
| dc.date.updated | 2026-11-10T12:07:50Z | - |
| dc.rights.holder | The Author | - |
| dc.contributor.orcid | Lau, Doreen [0000-0002-7623-2401] | - |
| dc.identifier.number | ltag024 | - |
| Appears in Collections: | Department of Life Sciences Research Papers | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| FullText.pdf | Copyright © The Author(s) 2026. Published by Oxford University Press on behalf of the British Society for Immunology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. | 185 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License